Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-25-011916
Filing Date
2025-04-14
Accepted
2025-04-14 16:11:14
Documents
19
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A govx20250407c_def14a.htm   iXBRL DEF 14A 817062
6 capnet.jpg GRAPHIC 32454
7 captsr.jpg GRAPHIC 34444
8 reynoldssig.jpg GRAPHIC 2253
  Complete submission text file 0001437749-25-011916.txt   1580716

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA govx-20241231.xsd EX-101.SCH 4076
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20241231_def.xml EX-101.DEF 1750
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20241231_lab.xml EX-101.LAB 1775
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20241231_pre.xml EX-101.PRE 714
21 EXTRACTED XBRL INSTANCE DOCUMENT govx20250407c_def14a_htm.xml XML 107169
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39563 | Film No.: 25836145
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)